001     300223
005     20250729100404.0
024 7 _ |a 10.1056/NEJMoa2415879
|2 doi
024 7 _ |a pmid:40162648
|2 pmid
024 7 _ |a 0028-4793
|2 ISSN
024 7 _ |a 1533-4406
|2 ISSN
024 7 _ |a altmetric:175672403
|2 altmetric
037 _ _ |a DKFZ-2025-00685
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Consortium, Global Cardiovascular Risk
|b 0
|e Collaboration Author
245 _ _ |a Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
260 _ _ |a Waltham, Mass.
|c 2025
|b MMS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753776197_3431
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Jul 10;393(2):125-138
520 _ _ |a Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular disease and death from any cause remains unclear.We harmonized individual-level data from 2,078,948 participants across 133 cohorts, 39 countries, and 6 continents. Lifetime risk of cardiovascular disease and death from any cause was estimated up to 90 years of age according to the presence or absence of arterial hypertension, hyperlipidemia, underweight and overweight or obesity, diabetes, and smoking at 50 years of age. Differences in life span (in terms of additional life-years free of cardiovascular disease or death from any cause) according to the presence or absence of these risk factors were also estimated. Risk-factor trajectories were analyzed to predict lifetime differences according to risk-factor variation.The lifetime risk of cardiovascular disease was 24% (95% confidence interval [CI], 21 to 30) among women and 38% (95% CI, 30 to 45) among men for whom all five risk factors were present. In the comparison between participants with none of the risk factors and those with all the risk factors, the estimated number of additional life-years free of cardiovascular disease was 13.3 (95% CI, 11.2 to 15.7) for women and 10.6 (95% CI, 9.2 to 12.9) for men; the estimated number of additional life-years free of death was 14.5 (95% CI, 9.1 to 15.3) for women and 11.8 (95% CI, 10.1 to 13.6) for men. As compared with no changes in the presence of all risk factors, modification of hypertension at an age of 55 to less than 60 years was associated with the most additional life-years free of cardiovascular disease, and modification of smoking at an age of 55 to less than 60 years was associated with the most additional life-years free of death.The absence of five classic risk factors at 50 years of age was associated with more than a decade greater life expectancy than the presence of all five risk factors, in both sexes. Persons who modified hypertension and smoking in midlife had the most additional life-years free of cardiovascular disease and death from any cause, respectively. (Funded by the German Center for Cardiovascular Research [DZHK]; ClinicalTrials.gov number, NCT05466825.).
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Magnussen, Christina
|0 0000-0002-5102-0955
|b 1
700 1 _ |a Alegre-Diaz, Jesus
|b 2
700 1 _ |a Al-Nasser, Lubna A
|b 3
700 1 _ |a Amouyel, Philippe
|b 4
700 1 _ |a Aviles-Santa, Larissa
|b 5
700 1 _ |a Bakker, Stephan J L
|b 6
700 1 _ |a Ballantyne, Christie M
|b 7
700 1 _ |a Bernabé-Ortiz, Antonio
|0 0000-0002-6834-1376
|b 8
700 1 _ |a Bobak, Martin
|b 9
700 1 _ |a Boffetta, Paolo
|b 10
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 11
|u dkfz
700 1 _ |a Brunström, Mattias
|b 12
700 1 _ |a Can, Gunay
|b 13
700 1 _ |a Carrillo-Larco, Rodrigo M
|b 14
700 1 _ |a Checkley, William
|0 0000-0003-1106-8812
|b 15
700 1 _ |a Dallongeville, Jean
|b 16
700 1 _ |a De Bacquer, Dirk
|b 17
700 1 _ |a de Gaetano, Giovanni
|b 18
700 1 _ |a de Lemos, James A
|b 19
700 1 _ |a di Carluccio, Eleonora
|b 20
700 1 _ |a Dobson, Annette
|b 21
700 1 _ |a Donfrancesco, Chiara
|b 22
700 1 _ |a Dörr, Marcus
|b 23
700 1 _ |a d'Orsi, Eleonora
|b 24
700 1 _ |a Drygas, Wojciech
|b 25
700 1 _ |a Dullaart, Robin P F
|b 26
700 1 _ |a Engström, Gunnar
|b 27
700 1 _ |a Ferrario, Marco M
|b 28
700 1 _ |a Ferrières, Jean
|b 29
700 1 _ |a Figtree, Gemma A
|b 30
700 1 _ |a Gaye, Bamba
|b 31
700 1 _ |a Ghayour-Mobarhan, Majid
|b 32
700 1 _ |a Goldbourt, Uri
|b 33
700 1 _ |a Gonzalez, Clicerio
|b 34
700 1 _ |a Gossling, Alina
|b 35
700 1 _ |a Grassi, Guido
|b 36
700 1 _ |a Gupta, Prakash C
|b 37
700 1 _ |a He, Jiang
|0 0000-0002-8286-9652
|b 38
700 1 _ |a Hodge, Allison M
|b 39
700 1 _ |a Hozawa, Atsushi
|b 40
700 1 _ |a Hveem, Kristian
|b 41
700 1 _ |a Iacoviello, Licia
|b 42
700 1 _ |a Ikram, M Kamran
|b 43
700 1 _ |a Inoue, Manami
|0 0000-0003-1276-2398
|b 44
700 1 _ |a Irazola, Vilma
|b 45
700 1 _ |a Jobe, Modou
|b 46
700 1 _ |a Jousilahti, Pekka
|b 47
700 1 _ |a Kaleebu, Pontiano
|b 48
700 1 _ |a Kavousi, Maryam
|b 49
700 1 _ |a Kee, Frank
|b 50
700 1 _ |a Khalili, Davood
|0 0000-0003-4956-1039
|b 51
700 1 _ |a Klotsche, Jens
|b 52
700 1 _ |a Koenig, Wolfgang
|b 53
700 1 _ |a Kontsevaya, Anna
|b 54
700 1 _ |a Kowlessur, Sudhirsen
|b 55
700 1 _ |a Kuri-Morales, Pablo
|b 56
700 1 _ |a Kuulasmaa, Kari
|b 57
700 1 _ |a Kweon, Sun-Seog
|b 58
700 1 _ |a Lackner, Karl J
|b 59
700 1 _ |a Landmesser, Ulf
|b 60
700 1 _ |a Leistner, David M
|b 61
700 1 _ |a Leiva Sisnieguez, Carlos E
|b 62
700 1 _ |a Leong, Darryl
|b 63
700 1 _ |a Lind, Lars
|b 64
700 1 _ |a Linneberg, Allan
|b 65
700 1 _ |a Lorenz, Thiess
|b 66
700 1 _ |a Lyngbakken, Magnus N
|b 67
700 1 _ |a Malekzadeh, Reza
|b 68
700 1 _ |a Malyutina, Sofia
|b 69
700 1 _ |a Mathiesen, Ellisiv B
|0 0000-0001-8887-6100
|b 70
700 1 _ |a McElduff, Patrick
|b 71
700 1 _ |a Melander, Olle
|b 72
700 1 _ |a Metspalu, Andres
|b 73
700 1 _ |a Miranda, J Jaime
|b 74
700 1 _ |a Moitry, Marie
|b 75
700 1 _ |a Mugisha, Joseph
|b 76
700 1 _ |a Munzinger, Julia
|b 77
700 1 _ |a Nalini, Mahdi
|b 78
700 1 _ |a Nambi, Vijay
|b 79
700 1 _ |a Nilsson, Peter M
|b 80
700 1 _ |a Ninomiya, Toshiharu
|b 81
700 1 _ |a Omland, Torbjørn
|b 82
700 1 _ |a Ong, Sok King
|b 83
700 1 _ |a Oppermann, Karen
|b 84
700 1 _ |a Pajak, Andrzej
|b 85
700 1 _ |a Palmieri, Luigi
|b 86
700 1 _ |a Panagiotakos, Demosthenes
|b 87
700 1 _ |a Park, Sue K
|b 88
700 1 _ |a Pednekar, Mangesh S
|b 89
700 1 _ |a Perianayagam, Arokiasamy
|b 90
700 1 _ |a Peters, Annette
|b 91
700 1 _ |a Poustchi, Hossein
|b 92
700 1 _ |a Prabhakaran, Dorairaj
|b 93
700 1 _ |a Prentice, Andrew M
|b 94
700 1 _ |a Prescott, Eva
|b 95
700 1 _ |a Quyyumi, Arshed
|b 96
700 1 _ |a Risérus, Ulf
|b 97
700 1 _ |a Sakata, Satoko
|b 98
700 1 _ |a Salazar, Martin
|b 99
700 1 _ |a Salomaa, Veikko
|b 100
700 1 _ |a Sans, Susana
|b 101
700 1 _ |a Sattler, E Lilian P
|b 102
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 103
|u dkfz
700 1 _ |a Schutte, Aletta E
|b 104
700 1 _ |a Sepanlou, Sadaf G
|b 105
700 1 _ |a Sharma, Sanjib K
|b 106
700 1 _ |a Shaw, Jonathan
|b 107
700 1 _ |a Simons, Leon A
|b 108
700 1 _ |a Söderberg, Stefan
|0 0000-0001-9225-1306
|b 109
700 1 _ |a Tamosiunas, Abdonas
|b 110
700 1 _ |a Tapia-Conyer, Roberto
|b 111
700 1 _ |a Thorand, Barbara
|b 112
700 1 _ |a Tunstall-Pedoe, Hugh
|b 113
700 1 _ |a Tuomilehto, Jaakko
|b 114
700 1 _ |a Twerenbold, Raphael
|b 115
700 1 _ |a Vanuzzo, Diego
|b 116
700 1 _ |a Veronesi, Giovanni
|b 117
700 1 _ |a Wannamethee, S Goya
|b 118
700 1 _ |a Watanabe, Masafumi
|b 119
700 1 _ |a Weimann, Jessica
|b 120
700 1 _ |a Wild, Philipp S
|b 121
700 1 _ |a Yao, Yao
|b 122
700 1 _ |a Zeng, Yi
|b 123
700 1 _ |a Ziegler, Andreas
|0 0000-0002-8386-5397
|b 124
700 1 _ |a Ojeda, Francisco M
|b 125
700 1 _ |a Blankenberg, Stefan
|b 126
773 _ _ |a 10.1056/NEJMoa2415879
|g p. NEJMoa2415879
|0 PERI:(DE-600)1468837-2
|n 2
|p 125-138
|t The New England journal of medicine
|v 393
|y 2025
|x 0028-4793
909 C O |p VDB
|o oai:inrepo02.dkfz.de:300223
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 103
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-18
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEW ENGL J MED : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-18
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-18
915 _ _ |a IF >= 90
|0 StatID:(DE-HGF)9990
|2 StatID
|b NEW ENGL J MED : 2022
|d 2024-12-18
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie der Krebsfrüherkennung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21